BioSante reacquires gel license

LINCOLNSHIRE - BioSante Pharmaceuticals Inc. announced Thursday that it has reacquired Elestrin (estradiol gel) from Nycomed US which in February acquired Bradley Pharmaceuticals Inc., BioSante's previous licensee of Elestrin. BioSante immediately will assume all manufacturing, distribution and marketing responsibilities for Elestrin. Elestrin is a fast-drying gel formulation of estradiol, the same estrogen produced naturally in women, and is U.S. Food and Drug Administration approved for the treatment of hot flashes in menopausal women.